Results 11 to 20 of about 413,699 (314)

Advances in Neurodegenerative Diseases

open access: yesNeurology International, 2022
A multitude of diseases presenting a wide variety of phenotypic appearances are included in neurodegenerative disorders [...
Efthimios Dardiotis, Vasileios Siokas
core   +4 more sources

Aquaporins and Neurodegenerative Diseases [PDF]

open access: yesCurrent Neuropharmacology, 2010
Aquaporins (AQPs) are a family of widely distributed membrane-inserted water channel proteins providing a pathway for osmotically-driven water, glycerol, urea or ions transport through cell membranes and mechanisms to control particular aspects of homeostasis.
Foglio E, RODELLA, Luigi Fabrizio
openaire   +2 more sources

Epilepsy in neurodegenerative diseases

open access: yesEpileptic Disorders, 2022
AbstractAlthough epilepsy as a comorbidity in neurodegenerative disorders is increasingly recognized, its incidence is still underestimated and the features of epilepsy in the different neurodegenerative conditions are still poorly defined. Improved health care, resulting in increased longevity, will unavoidably lead to an increment of epilepsy cases ...
Neri, Sabrina   +4 more
openaire   +3 more sources

Mitoepigenetics and Neurodegenerative Diseases [PDF]

open access: yesFrontiers in Endocrinology, 2019
Mitochondrial impairment and increased oxidative stress are common features in neurodegenerative disorders, leading researchers to speculate that epigenetic changes in the mitochondrial DNA (mitoepigenetics) could contribute to neurodegeneration.
Coppede F., Stoccoro A.
openaire   +3 more sources

Biomarkers in Neurodegenerative Diseases [PDF]

open access: yesBiomedicines, 2022
An increasing number of people are affected by various neurodegenerative diseases each year, impacting the quality of life of millions of people worldwide [...]
openaire   +3 more sources

Caregiver Burden in Movement Disorders and Neurodegenerative Diseases: Editorial

open access: yes, 2022
Caregiver burden is still an unmet need in the treatment of many neurodegenerative diseases [...
Martin Klietz, Klietz, Martin
core   +1 more source

TREM2 in Neurodegenerative Diseases [PDF]

open access: yesMolecular Neurodegeneration, 2017
TREM2 variants have been identified as risk factors for Alzheimer's disease (AD) and other neurodegenerative diseases (NDDs). Because TREM2 encodes a receptor exclusively expressed on immune cells, identification of these variants conclusively demonstrates that the immune response can play an active role in the pathogenesis of NDDs.
Jay, Taylor R.   +2 more
openaire   +3 more sources

Reelin Signaling in Neurodevelopmental Disorders and Neurodegenerative Diseases

open access: yes, 2023
Reelin is an extracellular matrix glycoprotein involved in neuronal migration during embryonic brain development and synaptic plasticity in the adult brain.
Aurelie Joly-Amado   +2 more
core   +1 more source

The lysosome and neurodegenerative diseases [PDF]

open access: yesActa Biochimica et Biophysica Sinica, 2009
It has long been believed that the lysosome is an important digestive organelle. There is increasing evidence that the lysosome is also involved in pathogenesis of a variety of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis.
Lisha, Zhang, Rui, Sheng, Zhenghong, Qin
openaire   +2 more sources

Sphingolipids in neurodegenerative diseases

open access: yesFrontiers in Neuroscience, 2023
Neurodegenerative Diseases (NDDs) are a group of disorders that cause progressive deficits of neuronal function. Recent evidence argues that sphingolipid metabolism is affected in a surprisingly broad set of NDDs. These include some lysosomal storage diseases (LSDs), hereditary sensory and autonomous neuropathy (HSAN), hereditary spastic paraplegia ...
Xueyang Pan   +8 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy